RadNet Q1 2026 earnings: revenue expands while margins stay under pressure

RadNet (RDNT) opened 2026 with Q1 revenue of US$575.6 million and a basic EPS loss of US$0.43, as the stock trades around US$58.19. The company has seen revenue move from US$471.4 million in Q1 2025 to US$575.6 million in Q1 2026, while quarterly EPS has shifted from a loss of US$0.51 to a loss of US$0.43 over the same period. This sets up a results season where investors are watching how quickly revenue scale can translate into steadier margins.

See our full analysis for RadNet.

With the headline numbers on the table, the next step is to set those results against the widely followed narratives about RadNet's growth potential, risk profile, and path to more stable profitability.

US$2.1b in trailing revenue, but losses still on the board

• Over the last twelve months, RadNet generated about US$2.1b in revenue while reporting a net loss of US$14.2 million and a trailing basic EPS loss of US$0.19, so the business is clearly scaling but not yet consistently profitable.
• Consensus narrative points to AI-driven imaging and workflow tools as key margin drivers. However, the trailing loss shows that, so far, higher volumes have not fully offset costs:
  • Supportive for the bullish angle, revenue on a trailing basis has moved up from US$1.8b in Q4 2024 to US$2.1b in Q1 2026, which lines up with expectations of above-industry revenue growth.
  • At the same time, the swing from a small profit of US$2.8 million in the Q4 2024 trailing window to a loss of US$14.2 million by Q1 2026 challenges the idea that margin expansion from AI and automation is already flowing through.

Over the last year, bulls argue that rising demand and AI tools will help those higher revenues eventually translate into steadier profits, and the dedicated bull case breaks down how that thesis might play out in more detail 🐂 RadNet Bull Case.

Quarter-to-quarter EPS swings show a still-volatile profit path

• Basic EPS moved from a near breakeven loss of US$0.01 in Q4 2025 to a larger loss of US$0.43 in Q1 2026, after having briefly reached positive EPS of US$0.19 in Q2 2025 and US$0.07 in Q3 2025, so profitability has been bouncing around rather than settling into a clear pattern.
• Bears focus on this choppy earnings path and heavy spending on AI and acquisitions, and the recent numbers give them some talking points:
  • Critics highlight that net income excluding extra items has moved from a profit of US$5.3 million in Q4 2024 to a loss of US$33.5 million in Q1 2026, which fits concern that spending on AI platforms and acquisitions is adding financial strain.
  • Those same bears also point to the trailing twelve month loss of US$14.2 million and weak interest coverage as signs that the company has limited room for error if reimbursement or demand growth turns out softer than expected.

For a closer look at the key risks that cautious investors focus on, and how they frame the downside case after these EPS swings, it is worth reading the opposing bear argument in full 🐻 RadNet Bear Case.

Mixed valuation picture at US$58.19 per share

• At a share price of US$58.19, RadNet trades on a P/S of 2.1x compared with 1.2x for the wider US Healthcare industry. An internal model cites a DCF fair value of about US$90.70 and analysts have an average price target of US$90.38, so current pricing sits noticeably below both of those reference points.
• What stands out in the consensus narrative is how it balances growth hopes with financing risk at this valuation:
  • On the reward side, analysts expect earnings to grow very strongly and to turn positive within three years, which helps explain why some are comfortable valuing the stock above today’s P/S multiple and price.
  • On the risk side, the fact that earnings did not cover interest costs over the last twelve months means any investor leaning on those higher value estimates is also relying on a clear improvement in profitability and cash generation relative to where the business is today.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for RadNet on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With a mix of optimism and concern running through these results, it makes sense to review the underlying data yourself and move quickly to form your own view. A good place to start is the 3 key rewards and 2 important warning signs.

Explore Alternatives

RadNet is growing revenue but still reports losses, volatile EPS and weak interest coverage. As a result, its path to consistent profitability and financial resilience remains uncertain.

If you want ideas that may offer steadier balance sheets and potentially less earnings volatility, start comparing opportunities in the solid balance sheet and fundamentals stocks screener (44 results) to see what else fits your risk comfort level.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.